Skip to main content
. 2015 Sep 25;62(2):181–189. doi: 10.1093/cid/civ837

Figure 1.

Figure 1.

Phenotypic profiles derived from antimicrobial susceptibility testing of isolates included in (A) PRIMERS I and (B) PRIMERS II. Notes: S highlighted with green denotes a susceptible interpretation for the drug, based on Clinical and Laboratory Standards Institute (CLSI) breakpoints. R highlighted with red denotes a resistant (or intermediate) interpretation, based on CLSI breakpoints.